| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein kinase activity | EPHB4 ROCK2 INSR INSRR ELP1 YES1 CDC7 IGF1R LATS1 EPHA2 PRKCE PRKCI ULK1 FGR TAF1L ULK2 EIF2AK3 WNK2 | 8.10e-10 | 600 | 99 | 18 | GO:0004672 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | EPHB4 ROCK2 HYKK INSR INSRR ELP1 YES1 CDC7 IGF1R LATS1 EPHA2 PRKCE PRKCI ULK1 FGR TAF1L ULK2 EIF2AK3 WNK2 | 1.68e-09 | 709 | 99 | 19 | GO:0016773 |
| GeneOntologyMolecularFunction | kinase activity | EPHB4 ROCK2 HYKK INSR INSRR ELP1 YES1 CDC7 IGF1R LATS1 EPHA2 PRKCE PRKCI ULK1 FGR TAF1L ULK2 EIF2AK3 WNK2 | 5.70e-09 | 764 | 99 | 19 | GO:0016301 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | EPHB4 ROCK2 HYKK POLE INSR INSRR ELP1 YES1 CDC7 IGF1R LATS1 EPHA2 PRKCE PRKCI ULK1 FGR TAF1L ULK2 EIF2AK3 WNK2 | 2.83e-08 | 938 | 99 | 20 | GO:0016772 |
| GeneOntologyMolecularFunction | insulin receptor activity | 1.18e-07 | 3 | 99 | 3 | GO:0005009 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 7.85e-06 | 145 | 99 | 7 | GO:0004713 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 1.77e-05 | 65 | 99 | 5 | GO:0004714 | |
| GeneOntologyMolecularFunction | glutamate binding | 4.14e-05 | 14 | 99 | 3 | GO:0016595 | |
| GeneOntologyMolecularFunction | insulin receptor substrate binding | 5.15e-05 | 15 | 99 | 3 | GO:0043560 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 6.48e-05 | 85 | 99 | 5 | GO:0019199 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 7.39e-05 | 446 | 99 | 10 | GO:0004674 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 8.06e-05 | 363 | 99 | 9 | GO:0106310 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 9.14e-05 | 18 | 99 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | protein-hormone receptor activity | 1.70e-04 | 22 | 99 | 3 | GO:0016500 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 1.88e-04 | 239 | 99 | 7 | GO:0031406 | |
| GeneOntologyMolecularFunction | insulin binding | 2.41e-04 | 5 | 99 | 2 | GO:0043559 | |
| GeneOntologyMolecularFunction | organic acid binding | 2.73e-04 | 254 | 99 | 7 | GO:0043177 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 3.17e-04 | 27 | 99 | 3 | GO:0008066 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.54e-04 | 28 | 99 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | amino acid binding | 4.76e-04 | 73 | 99 | 4 | GO:0016597 | |
| GeneOntologyMolecularFunction | extracellularly glutamate-gated ion channel activity | 5.03e-04 | 7 | 99 | 2 | GO:0005234 | |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 6.68e-04 | 8 | 99 | 2 | GO:0022849 | |
| GeneOntologyMolecularFunction | carboxy-lyase activity | 7.50e-04 | 36 | 99 | 3 | GO:0016831 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 8.13e-04 | 37 | 99 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase binding | 1.26e-03 | 43 | 99 | 3 | GO:0043548 | |
| GeneOntologyMolecularFunction | insulin-like growth factor I binding | 1.83e-03 | 13 | 99 | 2 | GO:0031994 | |
| GeneOntologyMolecularFunction | Hsp90 protein binding | 2.57e-03 | 55 | 99 | 3 | GO:0051879 | |
| GeneOntologyMolecularFunction | carbon-carbon lyase activity | 2.71e-03 | 56 | 99 | 3 | GO:0016830 | |
| GeneOntologyMolecularFunction | diacylglycerol-dependent serine/threonine kinase activity | 2.79e-03 | 16 | 99 | 2 | GO:0004697 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 2.85e-03 | 57 | 99 | 3 | GO:1904315 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 3.15e-03 | 17 | 99 | 2 | GO:0004970 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 3.30e-03 | 60 | 99 | 3 | GO:0099529 | |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 3.94e-03 | 19 | 99 | 2 | GO:0005520 | |
| GeneOntologyMolecularFunction | ephrin receptor activity | 3.94e-03 | 19 | 99 | 2 | GO:0005003 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 4.13e-03 | 65 | 99 | 3 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 4.13e-03 | 65 | 99 | 3 | GO:0022824 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 5.09e-03 | 70 | 99 | 3 | GO:0003777 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 1.67e-06 | 228 | 100 | 9 | GO:0046777 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | CARM1 TOX MCF2 GRID2 GRIN2B PLXND1 SYNGAP1 BMP7 IGF1R EPHA2 PALM PRKCI ULK1 CDH4 ULK2 | 1.35e-05 | 846 | 100 | 15 | GO:0120035 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | CARM1 TOX MCF2 GRID2 GRIN2B PLXND1 SYNGAP1 BMP7 IGF1R EPHA2 PALM PRKCI ULK1 CDH4 ULK2 | 1.71e-05 | 863 | 100 | 15 | GO:0031344 |
| GeneOntologyBiologicalProcess | negative regulation of neurogenesis | 2.15e-05 | 173 | 100 | 7 | GO:0050768 | |
| GeneOntologyBiologicalProcess | somatic sensory system development | 2.33e-05 | 2 | 100 | 2 | GO:0160038 | |
| GeneOntologyBiologicalProcess | negative regulation of nervous system development | 3.19e-05 | 184 | 100 | 7 | GO:0051961 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | CARM1 TOX MCF2 GRID2 PLXND1 SYNGAP1 BMP7 IGF1R PRKCI ULK1 CDH4 ULK2 | 4.07e-05 | 612 | 100 | 12 | GO:0010975 |
| GeneOntologyBiologicalProcess | regulation of nervous system development | PRTG MCF2 GRID2 PLXND1 SYNGAP1 BMP7 ABCC8 PRKCI ULK1 CDH4 ULK2 EIF2AK3 | 4.98e-05 | 625 | 100 | 12 | GO:0051960 |
| GeneOntologyBiologicalProcess | male sex determination | 5.91e-05 | 16 | 100 | 3 | GO:0030238 | |
| GeneOntologyBiologicalProcess | response to alkaline pH | 6.96e-05 | 3 | 100 | 2 | GO:0010446 | |
| GeneOntologyBiologicalProcess | response to pH | 9.32e-05 | 49 | 100 | 4 | GO:0009268 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | CARM1 ROCK2 GAD2 INSR INSRR GRIN2B DDX1 STAT6 ATF6 BMP7 IGF1R FBP1 ABCC8 PALM PRKCE PRKCI EIF2AK3 | 1.23e-04 | 1272 | 100 | 17 | GO:1901698 |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | 1.25e-04 | 307 | 100 | 8 | GO:0018105 | |
| GeneOntologyBiologicalProcess | ephrin receptor signaling pathway | 1.37e-04 | 54 | 100 | 4 | GO:0048013 | |
| GeneOntologyBiologicalProcess | response to hormone | CARM1 ROCK2 GAD2 UGT1A6 INSR INSRR STAT6 BMP7 IGF1R LATS1 FBP1 ABCC8 PRKCE PRKCI TAT | 1.45e-04 | 1042 | 100 | 15 | GO:0009725 |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | 1.63e-04 | 319 | 100 | 8 | GO:0018209 | |
| GeneOntologyBiologicalProcess | exocrine system development | 1.69e-04 | 57 | 100 | 4 | GO:0035272 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | ROCK2 PRTG ARHGEF28 MCF2 PLXND1 SYNGAP1 BMP7 IGF1R LATS1 EPHA2 CABP4 PALM ULK1 FGR CDH4 ULK2 | 1.94e-04 | 1194 | 100 | 16 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 2.00e-04 | 515 | 100 | 10 | GO:0050767 | |
| GeneOntologyBiologicalProcess | negative regulation of axonogenesis | 2.34e-04 | 62 | 100 | 4 | GO:0050771 | |
| GeneOntologyBiologicalProcess | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis | 2.35e-04 | 25 | 100 | 3 | GO:0002433 | |
| GeneOntologyBiologicalProcess | Fc-gamma receptor signaling pathway involved in phagocytosis | 2.35e-04 | 25 | 100 | 3 | GO:0038096 | |
| GeneOntologyBiologicalProcess | cell junction organization | ROCK2 CABP1 INSR MDGA2 GRID2 GRIN2B PLXND1 SYNGAP1 IGF1R ABCC8 EPHA2 PALM PRKCI CDH4 | 2.50e-04 | 974 | 100 | 14 | GO:0034330 |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | CARM1 ROCK2 SENP3 INSR YES1 CDC7 IGF1R LATS1 PRKCE PRKCI ULK1 FGR ULK2 EIF2AK3 | 2.56e-04 | 976 | 100 | 14 | GO:0018193 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ROCK2 PRTG ARHGEF28 MCF2 PLXND1 SYNGAP1 BMP7 IGF1R CABP4 ULK1 CDH4 ULK2 | 2.68e-04 | 748 | 100 | 12 | GO:0048667 |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | ROCK2 GAD2 ACER1 INSRR GRIN2B ABCB1 SYNGAP1 BMP7 IGF1R FBP1 ABCC8 CABP4 PALM PAM PRKCE EIF2AK3 NIPBL | 2.76e-04 | 1361 | 100 | 17 | GO:0009628 |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | ROCK2 ARHGEF28 MCF2 GRIN2B SYNGAP1 CELSR1 FBP1 HACE1 ULK1 SIPA1L2 | 2.84e-04 | 538 | 100 | 10 | GO:0007264 |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 3.47e-04 | 192 | 100 | 6 | GO:0050770 | |
| GeneOntologyBiologicalProcess | glutamatergic neuron differentiation | 3.69e-04 | 29 | 100 | 3 | GO:1905962 | |
| GeneOntologyBiologicalProcess | dendritic spine maintenance | 4.08e-04 | 30 | 100 | 3 | GO:0097062 | |
| GeneOntologyBiologicalProcess | axonogenesis | 4.23e-04 | 566 | 100 | 10 | GO:0007409 | |
| GeneOntologyBiologicalProcess | neuron projection development | CARM1 ROCK2 PRTG ARHGEF28 TOX MCF2 GRID2 PLXND1 SYNGAP1 BMP7 IGF1R PALM PRKCI ULK1 CDH4 ULK2 | 4.41e-04 | 1285 | 100 | 16 | GO:0031175 |
| GeneOntologyBiologicalProcess | sex determination | 4.50e-04 | 31 | 100 | 3 | GO:0007530 | |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | 5.63e-04 | 384 | 100 | 8 | GO:0032956 | |
| GeneOntologyBiologicalProcess | neuron development | CARM1 ROCK2 PRTG ARHGEF28 TOX MCF2 GRID2 PLXND1 SYNGAP1 BMP7 IGF1R CABP4 PALM PRKCI ULK1 CDH4 ULK2 | 6.33e-04 | 1463 | 100 | 17 | GO:0048666 |
| GeneOntologyBiologicalProcess | Fc receptor mediated stimulatory signaling pathway | 6.47e-04 | 35 | 100 | 3 | GO:0002431 | |
| GeneOntologyCellularComponent | insulin receptor complex | 4.11e-07 | 4 | 99 | 3 | GO:0005899 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.21e-05 | 10 | 99 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | dynein complex | 1.25e-04 | 54 | 99 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | glutamatergic synapse | ROCK2 CABP1 MDGA2 GRID2 GRIK1 GRIN2B PLXND1 YES1 SYNGAP1 IGF1R PRKCE PRKCI SIPA1L2 | 1.25e-04 | 817 | 99 | 13 | GO:0098978 |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 1.44e-04 | 56 | 99 | 4 | GO:0099091 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 2.20e-04 | 25 | 99 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | axon | CABP1 GAD2 PRTG INSR INSRR GRIK1 GRIN2B PLXND1 IGF1R CABP4 PALM ULK1 | 1.02e-03 | 891 | 99 | 12 | GO:0030424 |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 1.08e-03 | 335 | 99 | 7 | GO:0061695 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 1.27e-03 | 45 | 99 | 3 | GO:0008328 | |
| GeneOntologyCellularComponent | protein kinase complex | 1.30e-03 | 170 | 99 | 5 | GO:1902911 | |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 1.62e-03 | 49 | 99 | 3 | GO:0099092 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 1.72e-03 | 50 | 99 | 3 | GO:0098878 | |
| GeneOntologyCellularComponent | receptor complex | 1.75e-03 | 581 | 99 | 9 | GO:0043235 | |
| GeneOntologyCellularComponent | somatodendritic compartment | PCSK5 CABP1 GAD2 ACAD9 INSR TMPRSS5 GRID2 GRIK1 GRIN2B SYNGAP1 IGF1R PALM PAM ULK1 | 1.91e-03 | 1228 | 99 | 14 | GO:0036477 |
| Domain | PROTEIN_KINASE_ATP | EPHB4 ROCK2 INSR INSRR YES1 CDC7 IGF1R LATS1 EPHA2 PRKCE PRKCI ULK1 FGR ULK2 EIF2AK3 WNK2 | 2.77e-09 | 459 | 100 | 16 | PS00107 |
| Domain | Kinase-like_dom | EPHB4 ROCK2 HYKK INSR INSRR YES1 CDC7 IGF1R LATS1 EPHA2 PRKCE PRKCI ULK1 FGR ULK2 EIF2AK3 WNK2 | 4.10e-09 | 542 | 100 | 17 | IPR011009 |
| Domain | Prot_kinase_dom | EPHB4 ROCK2 INSR INSRR YES1 CDC7 IGF1R LATS1 EPHA2 PRKCE PRKCI ULK1 FGR ULK2 EIF2AK3 WNK2 | 6.80e-09 | 489 | 100 | 16 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | EPHB4 ROCK2 INSR INSRR YES1 CDC7 IGF1R LATS1 EPHA2 PRKCE PRKCI ULK1 FGR ULK2 EIF2AK3 WNK2 | 7.63e-09 | 493 | 100 | 16 | PS50011 |
| Domain | Protein_kinase_ATP_BS | EPHB4 ROCK2 INSR INSRR YES1 CDC7 IGF1R EPHA2 PRKCE PRKCI ULK1 FGR ULK2 EIF2AK3 | 1.44e-08 | 379 | 100 | 14 | IPR017441 |
| Domain | Tyr_kinase_insulin-like_rcpt | 1.49e-07 | 3 | 100 | 3 | IPR016246 | |
| Domain | TyrKc | 4.54e-07 | 88 | 100 | 7 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 4.54e-07 | 88 | 100 | 7 | IPR020635 | |
| Domain | PROTEIN_KINASE_TYR | 8.84e-07 | 97 | 100 | 7 | PS00109 | |
| Domain | Tyr_kinase_AS | 8.84e-07 | 97 | 100 | 7 | IPR008266 | |
| Domain | Furin_repeat | 2.23e-06 | 18 | 100 | 4 | IPR006212 | |
| Domain | FU | 2.23e-06 | 18 | 100 | 4 | SM00261 | |
| Domain | Furin-like | 5.13e-06 | 7 | 100 | 3 | PF00757 | |
| Domain | Rcpt_L-dom | 5.13e-06 | 7 | 100 | 3 | IPR000494 | |
| Domain | Furin-like_Cys-rich_dom | 5.13e-06 | 7 | 100 | 3 | IPR006211 | |
| Domain | Recep_L_domain | 5.13e-06 | 7 | 100 | 3 | PF01030 | |
| Domain | - | 5.13e-06 | 7 | 100 | 3 | 3.80.20.20 | |
| Domain | Pkinase_Tyr | 5.98e-06 | 129 | 100 | 7 | PF07714 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 9.32e-06 | 138 | 100 | 7 | IPR001245 | |
| Domain | Growth_fac_rcpt_ | 2.07e-05 | 156 | 100 | 7 | IPR009030 | |
| Domain | Tyr_kinase_rcpt_2_CS | 2.38e-05 | 11 | 100 | 3 | IPR002011 | |
| Domain | Ser/Thr_kinase_C | 2.84e-05 | 2 | 100 | 2 | IPR022708 | |
| Domain | DUF3543 | 2.84e-05 | 2 | 100 | 2 | PF12063 | |
| Domain | FGR | 2.84e-05 | 2 | 100 | 2 | IPR028459 | |
| Domain | Ser/Thr_kin_STPK_Ulk-1/2 | 2.84e-05 | 2 | 100 | 2 | IPR016237 | |
| Domain | RECEPTOR_TYR_KIN_II | 3.16e-05 | 12 | 100 | 3 | PS00239 | |
| Domain | Pkinase_C | 4.46e-05 | 37 | 100 | 4 | IPR017892 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.19e-05 | 14 | 100 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 5.19e-05 | 14 | 100 | 3 | IPR024743 | |
| Domain | MT | 5.19e-05 | 14 | 100 | 3 | PF12777 | |
| Domain | AAA_8 | 5.19e-05 | 14 | 100 | 3 | PF12780 | |
| Domain | DHC_fam | 6.47e-05 | 15 | 100 | 3 | IPR026983 | |
| Domain | Dynein_heavy_dom | 6.47e-05 | 15 | 100 | 3 | IPR004273 | |
| Domain | Dynein_heavy | 6.47e-05 | 15 | 100 | 3 | PF03028 | |
| Domain | Pkinase_C | 7.41e-05 | 42 | 100 | 4 | PF00433 | |
| Domain | FN3 | 9.73e-05 | 199 | 100 | 7 | PS50853 | |
| Domain | Iontro_rcpt | 1.15e-04 | 18 | 100 | 3 | IPR001320 | |
| Domain | Lig_chan-Glu_bd | 1.15e-04 | 18 | 100 | 3 | PF10613 | |
| Domain | Iono_rcpt_met | 1.15e-04 | 18 | 100 | 3 | IPR001508 | |
| Domain | Glu/Gly-bd | 1.15e-04 | 18 | 100 | 3 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 1.15e-04 | 18 | 100 | 3 | SM00918 | |
| Domain | Lig_chan | 1.15e-04 | 18 | 100 | 3 | PF00060 | |
| Domain | PBPe | 1.15e-04 | 18 | 100 | 3 | SM00079 | |
| Domain | Ser/Thr_kinase_AS | 1.27e-04 | 357 | 100 | 9 | IPR008271 | |
| Domain | FN3_dom | 1.32e-04 | 209 | 100 | 7 | IPR003961 | |
| Domain | S_TKc | 1.32e-04 | 359 | 100 | 9 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 1.41e-04 | 362 | 100 | 9 | PS00108 | |
| Domain | Ca-bd_2 | 1.69e-04 | 4 | 100 | 2 | IPR015754 | |
| Domain | Pkinase | 2.07e-04 | 381 | 100 | 9 | PF00069 | |
| Domain | AGC-kinase_C | 2.30e-04 | 56 | 100 | 4 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 2.30e-04 | 56 | 100 | 4 | PS51285 | |
| Domain | S_TK_X | 2.30e-04 | 56 | 100 | 4 | SM00133 | |
| Domain | fn3 | 2.36e-04 | 162 | 100 | 6 | PF00041 | |
| Domain | C1_1 | 2.46e-04 | 57 | 100 | 4 | PF00130 | |
| Domain | Ephrin_rec_like | 3.14e-04 | 25 | 100 | 3 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 3.14e-04 | 25 | 100 | 3 | IPR011641 | |
| Domain | ZF_DAG_PE_1 | 3.84e-04 | 64 | 100 | 4 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 3.84e-04 | 64 | 100 | 4 | PS50081 | |
| Domain | C1 | 4.08e-04 | 65 | 100 | 4 | SM00109 | |
| Domain | PE/DAG-bd | 4.32e-04 | 66 | 100 | 4 | IPR002219 | |
| Domain | FN3 | 4.80e-04 | 185 | 100 | 6 | SM00060 | |
| Domain | ANF_lig-bd_rcpt | 1.01e-03 | 37 | 100 | 3 | IPR001828 | |
| Domain | ANF_receptor | 1.01e-03 | 37 | 100 | 3 | PF01094 | |
| Domain | Peripla_BP_I | 1.18e-03 | 39 | 100 | 3 | IPR028082 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 2.48e-03 | 14 | 100 | 2 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 2.48e-03 | 14 | 100 | 2 | PS00790 | |
| Domain | Eph_TM | 2.48e-03 | 14 | 100 | 2 | IPR027936 | |
| Domain | Tyr_kinase_rcpt_V_CS | 2.48e-03 | 14 | 100 | 2 | IPR001426 | |
| Domain | EPH_lbd | 2.48e-03 | 14 | 100 | 2 | SM00615 | |
| Domain | Dynein_heavy_dom-2 | 2.48e-03 | 14 | 100 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.48e-03 | 14 | 100 | 2 | PF08393 | |
| Domain | Ephrin_lbd | 2.48e-03 | 14 | 100 | 2 | PF01404 | |
| Domain | EphA2_TM | 2.48e-03 | 14 | 100 | 2 | PF14575 | |
| Domain | Tyr_kinase_ephrin_rcpt | 2.48e-03 | 14 | 100 | 2 | IPR016257 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 2.48e-03 | 14 | 100 | 2 | IPR001090 | |
| Domain | EPH_LBD | 2.48e-03 | 14 | 100 | 2 | PS51550 | |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 1.02e-06 | 98 | 77 | 7 | M39830 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 3.10e-06 | 42 | 77 | 5 | M27308 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 1.07e-05 | 92 | 77 | 6 | M27201 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 2.73e-05 | 65 | 77 | 5 | MM14911 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 4.74e-05 | 37 | 77 | 4 | MM15022 | |
| Pathway | WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH | 2.57e-04 | 23 | 77 | 3 | M39325 | |
| Pubmed | CARM1 EPHB4 PCSK5 CABP1 DNAH10 INSR PLXND1 YES1 CES2 IGF1R LATS1 CABP4 PRKCE PRKCI ULK1 FGR TAF1L ULK2 WNK2 | 2.82e-13 | 730 | 100 | 19 | 34857952 | |
| Pubmed | ROCK2 INSR YES1 AKAP8L IARS2 IGF1R EPHA2 PALM STEAP3 PRKCI MICAL3 SIPA1L2 | 3.41e-09 | 421 | 100 | 12 | 36976175 | |
| Pubmed | 4.56e-09 | 83 | 100 | 7 | 11114734 | ||
| Pubmed | Sexually dimorphic behavior, neuronal activity, and gene expression in Chd8-mutant mice. | 1.40e-08 | 56 | 100 | 6 | 30104731 | |
| Pubmed | Insulin receptor-related receptor as an extracellular alkali sensor. | 2.31e-08 | 3 | 100 | 3 | 21641549 | |
| Pubmed | 2.31e-08 | 3 | 100 | 3 | 21681845 | ||
| Pubmed | EPHB4 ACAD9 POLE ELP1 UNC45A YES1 NSDHL ATF6 IARS2 SEC24C PMPCA EPHA2 PALM STEAP3 PRKCI SIPA1L2 EIF2AK3 DCAF7 | 2.25e-07 | 1487 | 100 | 18 | 33957083 | |
| Pubmed | The phosphotyrosine interactome of the insulin receptor family and its substrates IRS-1 and IRS-2. | 2.30e-07 | 5 | 100 | 3 | 19001411 | |
| Pubmed | PCSK5 ARHGEF28 POLE SENP3 ELP1 AKAP8L DDX1 PAM PRKCI MICAL3 ULK1 HPS5 | 3.86e-07 | 650 | 100 | 12 | 38777146 | |
| Pubmed | Role of Unc51.1 and its binding partners in CNS axon outgrowth. | 4.58e-07 | 6 | 100 | 3 | 15014045 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPHB4 PCSK5 POLE PLXND1 CELSR1 IGF1R PALM STEAP3 MICAL3 ULK1 SIPA1L2 ULK2 ABTB2 TEX19 WNK2 | 6.28e-07 | 1105 | 100 | 15 | 35748872 |
| Pubmed | Identification of tyrosine kinases expressed in the male mouse gubernaculum during development. | 7.77e-07 | 25 | 100 | 4 | 15254900 | |
| Pubmed | Comparative analysis of the signaling capabilities of the insulin receptor-related receptor. | 1.28e-06 | 8 | 100 | 3 | 15629149 | |
| Pubmed | 5.43e-06 | 40 | 100 | 4 | 30898150 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | CARM1 POLE ECHDC1 ELP1 YES1 NSDHL IARS2 STXBP2 SEC24C PRKCI NIPBL | 5.99e-06 | 704 | 100 | 11 | 29955894 |
| Pubmed | Testis determination requires insulin receptor family function in mice. | 6.46e-06 | 13 | 100 | 3 | 14628051 | |
| Pubmed | Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. | 6.46e-06 | 13 | 100 | 3 | 20859245 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 22438913 | ||
| Pubmed | Conservation of structure, function and inhibitor binding in UNC-51-like kinase 1 and 2 (ULK1/2). | 8.18e-06 | 2 | 100 | 2 | 30782972 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 38383709 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 24809298 | ||
| Pubmed | A kinase-independent role for unoccupied insulin and IGF-1 receptors in the control of apoptosis. | 8.18e-06 | 2 | 100 | 2 | 21139139 | |
| Pubmed | The insulin and IGF1 receptor kinase domains are functional dimers in the activated state. | 8.18e-06 | 2 | 100 | 2 | 25758790 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 30717233 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 14654552 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 27384680 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 35786404 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 28138037 | ||
| Pubmed | Distinct functions of Ulk1 and Ulk2 in the regulation of lipid metabolism in adipocytes. | 8.18e-06 | 2 | 100 | 2 | 24135897 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 30070361 | ||
| Pubmed | Ca2+-binding proteins tune Ca2+-feedback to Cav1.3 channels in mouse auditory hair cells. | 8.18e-06 | 2 | 100 | 2 | 17947313 | |
| Pubmed | A synaptic Ras-GTPase activating protein (p135 SynGAP) inhibited by CaM kinase II. | 8.18e-06 | 2 | 100 | 2 | 9620694 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 31562314 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 11463843 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 14722023 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 17416680 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 33149253 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 22692545 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 21177763 | ||
| Pubmed | ULK1/2 Constitute a Bifurcate Node Controlling Glucose Metabolic Fluxes in Addition to Autophagy. | 8.18e-06 | 2 | 100 | 2 | 27153534 | |
| Pubmed | Evaluation of EphA2 and EphB4 as Targets for Image-Guided Colorectal Cancer Surgery. | 8.18e-06 | 2 | 100 | 2 | 28165374 | |
| Pubmed | Changes in insulin and IGF-I receptor expression during differentiation of human preadipocytes. | 8.18e-06 | 2 | 100 | 2 | 18693051 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 19817984 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 19744489 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 28065828 | ||
| Pubmed | Insulin signaling in the hippocampus and amygdala regulates metabolism and neurobehavior. | 8.18e-06 | 2 | 100 | 2 | 30765523 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 24302626 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 22879999 | ||
| Pubmed | Leucine-973 is a crucial residue differentiating insulin and IGF-1 receptor signaling. | 8.18e-06 | 2 | 100 | 2 | 36548088 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 17189427 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 22541124 | ||
| Pubmed | A functional assessment of insulin/insulin-like growth factor-I hybrid receptors. | 8.18e-06 | 2 | 100 | 2 | 7895674 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 19851056 | ||
| Pubmed | Regulation of nutrient-sensitive autophagy by uncoordinated 51-like kinases 1 and 2. | 8.18e-06 | 2 | 100 | 2 | 23291478 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 28030849 | ||
| Pubmed | PKCλ/ι inhibition activates an ULK2-mediated interferon response to repress tumorigenesis. | 8.18e-06 | 2 | 100 | 2 | 34560002 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 19406949 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 27905925 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 32849999 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 19524295 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 18650937 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 34658916 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 30213860 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 22161861 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 29040448 | ||
| Pubmed | Scleral PERK and ATF6 as targets of myopic axial elongation of mouse eyes. | 8.18e-06 | 2 | 100 | 2 | 36216837 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 19139090 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 8916919 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 35964946 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 12813019 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 21474992 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 28050756 | ||
| Pubmed | Total insulin and IGF-I resistance in pancreatic beta cells causes overt diabetes. | 8.18e-06 | 2 | 100 | 2 | 16642022 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 28407051 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 9819385 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 26438154 | ||
| Pubmed | Insulin and IGF-I inhibit GH synthesis and release in vitro and in vivo by separate mechanisms. | 8.18e-06 | 2 | 100 | 2 | 23671263 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 31088290 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 26862994 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 18708119 | ||
| Pubmed | Role of insulin receptor in the regulation of glucose uptake in neonatal hepatocytes. | 8.18e-06 | 2 | 100 | 2 | 16644916 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 1660482 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 25246545 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 37210550 | ||
| Pubmed | Identification of mouse ULK1, a novel protein kinase structurally related to C. elegans UNC-51. | 8.18e-06 | 2 | 100 | 2 | 9600096 | |
| Pubmed | Lipodystrophy Due to Adipose Tissue-Specific Insulin Receptor Knockout Results in Progressive NAFLD. | 8.18e-06 | 2 | 100 | 2 | 27207510 | |
| Pubmed | Differential Roles of Insulin and IGF-1 Receptors in Adipose Tissue Development and Function. | 8.18e-06 | 2 | 100 | 2 | 27207537 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 25017244 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 27037060 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 18711691 | ||
| Pubmed | The requirement of uncoordinated 51-like kinase 1 (ULK1) and ULK2 in the regulation of autophagy. | 8.18e-06 | 2 | 100 | 2 | 21460635 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 27088794 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 7931420 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 26850678 | ||
| Pubmed | Insulin, insulin receptor and insulin-like growth factor-I receptor on the human ocular surface. | 8.18e-06 | 2 | 100 | 2 | 12613967 | |
| Pubmed | Signalling through the insulin receptor and the insulin-like growth factor-I receptor. | 8.18e-06 | 2 | 100 | 2 | 7821728 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 21908557 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 12014989 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 26251471 | ||
| Pubmed | Differential Role of Insulin/IGF-1 Receptor Signaling in Muscle Growth and Glucose Homeostasis. | 8.18e-06 | 2 | 100 | 2 | 25981038 | |
| Interaction | GJA1 interactions | ROCK2 INSR YES1 NSDHL IARS2 IGF1R STXBP2 EPHA2 PALM STEAP3 PRKCE ULK1 SIPA1L2 EIF2AK3 | 8.60e-07 | 583 | 98 | 14 | int:GJA1 |
| Interaction | DUSP26 interactions | 9.98e-06 | 59 | 98 | 5 | int:DUSP26 | |
| Interaction | CDC37 interactions | EPHB4 INSR INSRR BIRC3 UNC45A YES1 IGF1R LATS1 EPHA2 PRKCE PRKCI ULK1 FGR | 1.45e-05 | 645 | 98 | 13 | int:CDC37 |
| Cytoband | 12q24.3 | 7.01e-05 | 6 | 100 | 2 | 12q24.3 | |
| Cytoband | 2p24 | 3.06e-04 | 12 | 100 | 2 | 2p24 | |
| Cytoband | 9q22.3 | 3.06e-04 | 12 | 100 | 2 | 9q22.3 | |
| Cytoband | 19p13.3-p13.2 | 4.20e-04 | 14 | 100 | 2 | 19p13.3-p13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 1.84e-03 | 797 | 100 | 7 | chr19p13 | |
| Cytoband | 15q21.3 | 2.67e-03 | 35 | 100 | 2 | 15q21.3 | |
| GeneFamily | Dyneins, axonemal | 3.96e-05 | 17 | 72 | 3 | 536 | |
| GeneFamily | Fibronectin type III domain containing | 4.22e-05 | 160 | 72 | 6 | 555 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 5.38e-04 | 40 | 72 | 3 | 321 | |
| GeneFamily | Maestro heat like repeat containing | 8.40e-04 | 11 | 72 | 2 | 636 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 1.38e-03 | 14 | 72 | 2 | 1095 | |
| GeneFamily | Autophagy related | 7.62e-03 | 33 | 72 | 2 | 1022 | |
| GeneFamily | SH2 domain containing | 7.64e-03 | 101 | 72 | 3 | 741 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.34e-09 | 162 | 100 | 8 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.38e-07 | 145 | 100 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.06e-06 | 148 | 100 | 6 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.09e-06 | 178 | 100 | 6 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | (05)_Ciliated-(4)_1wkpi|(05)_Ciliated / shred by cell type and Timepoint | 3.29e-06 | 180 | 100 | 6 | 85fc9b164147b28545e2397d32302eea03ef6346 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.06e-06 | 194 | 100 | 6 | 83863da11dfbe59b2d0a2c08db40b537c150588c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.06e-06 | 194 | 100 | 6 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 5.69e-06 | 198 | 100 | 6 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.69e-06 | 198 | 100 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 5.69e-06 | 198 | 100 | 6 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.86e-06 | 199 | 100 | 6 | 121de4e02585de3a3010398387c523bacf8ce546 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.03e-06 | 200 | 100 | 6 | a9cdddc4e985dae59521e557479c24fcc2ac727d | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.03e-06 | 200 | 100 | 6 | cf191104484bfb2b9f87de416b9453135f8833c1 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.03e-06 | 200 | 100 | 6 | 33b9199e0dfc267e2cea20b82d1c167f8adcc635 | |
| ToppCell | LPS_IL1RA-Epithelial_airway|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.03e-06 | 200 | 100 | 6 | a5ae33dd4dc1ff6e1a1eec22c4d523d5ab657607 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.03e-06 | 200 | 100 | 6 | 9719fabddc34051949468a7520289e3c750de4f8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-05 | 147 | 100 | 5 | 2885978bcfc5623967c0c1204dadf5c78c74a082 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal--glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 154 | 100 | 5 | 3211f003f4d1735c7cab9b6cc68af3e0bbfba35e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 154 | 100 | 5 | c0fe767fc9ab45b2dfa71171f2a673a4a8decbaf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 154 | 100 | 5 | 4c2a7590791c2255b15dab82c3622f71f9ffd949 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 160 | 100 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 160 | 100 | 5 | f2cdee5a9e3b0eb125d6be7b5d239eb04333ae41 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.06e-05 | 160 | 100 | 5 | dd16ca90feb3ae88b6409d6c278b4765da565514 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 160 | 100 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.16e-05 | 161 | 100 | 5 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-05 | 161 | 100 | 5 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.45e-05 | 164 | 100 | 5 | 4cfc9f92e49f86d3639e018b35b6a60dc62f494a | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.45e-05 | 164 | 100 | 5 | 7a8e5ef52a8fd2877d59ef0696af8a7af90bbed6 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.45e-05 | 164 | 100 | 5 | 5e5bd81414ea2d64f73cdef19a0a78c17bec8c18 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.45e-05 | 164 | 100 | 5 | f13b8d9b7f42193f333d9a77571a1dde6bbb48d8 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.87e-05 | 168 | 100 | 5 | a74c8a9e3299183fba31ce3053ef325b5dbcd104 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.87e-05 | 168 | 100 | 5 | 0f736d58cb0ff042fa3ce58e36bde37b6976f8fc | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.87e-05 | 168 | 100 | 5 | dae37b316ce80dfe4236c4ed7f0d4e7c340fa7b6 | |
| ToppCell | metastatic_Brain-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 3.87e-05 | 168 | 100 | 5 | 4bf3f85aac4b335efa93d22c9ce7b153cb5ce152 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.87e-05 | 168 | 100 | 5 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.98e-05 | 169 | 100 | 5 | 78eb70dd916724e476eabccf18fb7fcec4210308 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-05 | 170 | 100 | 5 | 99dd734c0972a40d5381e8e2d96bdaa31f6d06e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-05 | 170 | 100 | 5 | 3a14eeae221b8bb0bd0dadcb8e7a603431240a1e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-05 | 170 | 100 | 5 | cdb6fad277f284c3fd5a6f45672a8edc24715882 | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-Cd3e_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-05 | 173 | 100 | 5 | f2eeff86e7dc7f4e3c36f775777d56685d7096cf | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.57e-05 | 174 | 100 | 5 | 096bc6f1889f2bbadfe1e1a3eb6ae569aaa2ee7d | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.70e-05 | 175 | 100 | 5 | e7b0eda141b638f1aad9938aaa76b1ce80171be9 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_C|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.09e-05 | 178 | 100 | 5 | 7203149864cc8d5ae25329fdbf15c6b73c3d3595 | |
| ToppCell | COVID-19-Myeloid-MoAM4|Myeloid / Condition, Lineage and Cell class | 5.09e-05 | 178 | 100 | 5 | fe0017e6a1f23dc45f644b9acacc7e8aa80d0116 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.23e-05 | 179 | 100 | 5 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.23e-05 | 179 | 100 | 5 | ec1d7017da325647b629de703135a404bbdc627d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-05 | 180 | 100 | 5 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.51e-05 | 181 | 100 | 5 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.51e-05 | 181 | 100 | 5 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.66e-05 | 182 | 100 | 5 | fbe5bdd642b86010dbef0a567b25c69c7335688f | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-Cd3e_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.66e-05 | 182 | 100 | 5 | da3e9093cba791c7c282eb044656046252a32789 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.80e-05 | 183 | 100 | 5 | f8b636391f752e379a5c5575fd898bdf0907a3b8 | |
| ToppCell | Epithelial-lung_goblet_cell|World / Lineage, Cell type, age group and donor | 5.80e-05 | 183 | 100 | 5 | 940cbe298e9c53b5622af09264586ed823d3141f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 184 | 100 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 184 | 100 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 184 | 100 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.11e-05 | 185 | 100 | 5 | 487fa382232564f075960899d50afa0edae5d258 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.11e-05 | 185 | 100 | 5 | 4c42bd3cd72f91f4d4ebb849069a03761a2cd662 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.27e-05 | 186 | 100 | 5 | 55fe25f4d0f2bc0fd4802a0a375169f2c41472fc | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.27e-05 | 186 | 100 | 5 | 32af3f211f9ad5d5c6b86b83325cfbf2f8466b56 | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.43e-05 | 187 | 100 | 5 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.43e-05 | 187 | 100 | 5 | 9042bd0f57213a51503d9df2e4dce3209b7772d3 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.43e-05 | 187 | 100 | 5 | 42b20d7f0a4f9195b3d71dc0e089b5e0914ebcbb | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.59e-05 | 188 | 100 | 5 | 8268574584e5fb869a6cb8bbd7135cd7454a6a25 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.59e-05 | 188 | 100 | 5 | 73f6ec915934154f435a376cb274b058ff7c5f35 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.59e-05 | 188 | 100 | 5 | 4544552ebd67e9eb3e40d8511bb2b03a6e1178f8 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.59e-05 | 188 | 100 | 5 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.76e-05 | 189 | 100 | 5 | d17e8467699c7ca7694a313c26111f085df5204e | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 6.76e-05 | 189 | 100 | 5 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 6.93e-05 | 190 | 100 | 5 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.93e-05 | 190 | 100 | 5 | a1514d2186eb4fe569971ab22dc0c17d353fb94a | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.93e-05 | 190 | 100 | 5 | 0bb954a94317cfc742b9b6221bb80f8baa6d3ff1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.93e-05 | 190 | 100 | 5 | b7f8c2bb9459f1d7c1690069dd5a25a81a57cc84 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 6.93e-05 | 190 | 100 | 5 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.93e-05 | 190 | 100 | 5 | 26e2237f65cb43723c5da853831b40df2982d6e4 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 7.28e-05 | 192 | 100 | 5 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.28e-05 | 192 | 100 | 5 | 2510f22197502f60fd266b7f42eff040f25b8ae7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.28e-05 | 192 | 100 | 5 | e8e316f396834bcd34843e56e1d86f310fd6aada | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.28e-05 | 192 | 100 | 5 | 1b6cac8156e608061e1405e36e18d185b6fa8f6f | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.46e-05 | 193 | 100 | 5 | d0a5f212f8e8a13dbbe3e41df92548ef82eef70b | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.46e-05 | 193 | 100 | 5 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.46e-05 | 193 | 100 | 5 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.46e-05 | 193 | 100 | 5 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.46e-05 | 193 | 100 | 5 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.46e-05 | 193 | 100 | 5 | 658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.46e-05 | 193 | 100 | 5 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.65e-05 | 194 | 100 | 5 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.65e-05 | 194 | 100 | 5 | 0cd4363627acd419e00d6d32f6dce10430aa6487 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-Secretory/RAS-RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.65e-05 | 194 | 100 | 5 | a58841b34efe673671a9a059238e044a7254b279 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.65e-05 | 194 | 100 | 5 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.65e-05 | 194 | 100 | 5 | 1bcb3fafd498614f7bac2b1c9b7de56e39110f65 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.83e-05 | 195 | 100 | 5 | 441345d33f839a9e9222e790752b5603ff572bf2 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.83e-05 | 195 | 100 | 5 | 2a9a36df1dbc4eac77a8ddbe939ec8a8d6c41464 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.83e-05 | 195 | 100 | 5 | cfcf554b436083179dea1d6fd6e3a800ea2430fe | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.83e-05 | 195 | 100 | 5 | 576142b4e75457c0973051bccc4163bd624496af | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.83e-05 | 195 | 100 | 5 | 8f151066ad3ebd9661ea0b733f03c2ce1518f9ad | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.83e-05 | 195 | 100 | 5 | 3d6d3de8ada6dce3dc789c15b50cc066e7100496 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.22e-05 | 197 | 100 | 5 | 107cb153ea7fc74bbd244dbb9d0499c0a8506724 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.42e-05 | 198 | 100 | 5 | 8d629492d2199de8e036c19e9dacceb9c9e721a0 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type | 8.42e-05 | 198 | 100 | 5 | e035380578c01b0243bfef29ca9b50cc17cce771 | |
| Drug | phenobarbital | UGT1A6 CYP21A2 GRID2 GRIK1 GRIN2B CES2 ABCB1 GSTA3 PRKCE PRKCI TAT | 5.35e-07 | 360 | 100 | 11 | CID000004763 |
| Drug | 2-amino-3-phosphonopropionic acid | 1.05e-06 | 76 | 100 | 6 | CID000003857 | |
| Drug | soman | 3.24e-06 | 92 | 100 | 6 | CID000007305 | |
| Drug | VX-745 | 4.13e-06 | 25 | 100 | 4 | CID003038525 | |
| Drug | Rose Bengal | 6.77e-06 | 9 | 100 | 3 | ctd:D012395 | |
| Drug | Fce 26644 | 6.77e-06 | 9 | 100 | 3 | CID000132977 | |
| Drug | Dichlorodiphenyl Dichloroethylene | 7.46e-06 | 302 | 100 | 9 | ctd:D003633 | |
| Drug | L-Glutamic Acid | 1.24e-05 | 68 | 100 | 5 | DB00142 | |
| Drug | 1xgj | 1.24e-05 | 68 | 100 | 5 | CID000657106 | |
| Drug | 1-aminoindan-1,5-dicarboxylic acid | 1.30e-05 | 33 | 100 | 4 | CID000002071 | |
| Drug | felbamate | 1.43e-05 | 70 | 100 | 5 | CID000003331 | |
| Drug | cystamine | 1.53e-05 | 181 | 100 | 7 | CID000002915 | |
| Drug | N-methyl-N-(6-methoxy-1-phenyl-1,2,3,4-tetrahydronaphthalen-2-ylmethyl)aminomethylcarboxylic acid | 1.65e-05 | 35 | 100 | 4 | ctd:C520612 | |
| Drug | BCECF | 1.75e-05 | 73 | 100 | 5 | CID004241719 | |
| Drug | C6H12NO5P | 1.85e-05 | 36 | 100 | 4 | CID000104962 | |
| Drug | Insulin Glargine | 1.91e-05 | 2 | 100 | 2 | ctd:D000069036 | |
| Drug | Insulin Lispro | 1.91e-05 | 2 | 100 | 2 | DB00046 | |
| Drug | Insulin Glargine | 1.91e-05 | 2 | 100 | 2 | DB00047 | |
| Drug | NC-1100 | 1.91e-05 | 2 | 100 | 2 | CID000146395 | |
| Drug | Tamoxifen citrate [54965-24-1]; Down 200; 7uM; PC3; HT_HG-U133A | 2.48e-05 | 195 | 100 | 7 | 2050_DN | |
| Drug | 16-phenyl tetranor Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | 2.65e-05 | 197 | 100 | 7 | 7546_DN | |
| Drug | Riluzole hydrochloride; Up 200; 14.8uM; PC3; HT_HG-U133A | 2.65e-05 | 197 | 100 | 7 | 3666_UP | |
| Drug | CP-690334-01 [459212-38-5]; Up 200; 1uM; MCF7; HT_HG-U133A | 2.74e-05 | 198 | 100 | 7 | 4383_UP | |
| Drug | Adamantamine fumarate [80789-67-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 2.83e-05 | 199 | 100 | 7 | 3280_UP | |
| Drug | thiokynurenic acid | 3.60e-05 | 15 | 100 | 3 | CID003035667 | |
| Drug | amphetamine | 3.66e-05 | 284 | 100 | 8 | CID000003007 | |
| Drug | Joro spider toxin | 3.79e-05 | 43 | 100 | 4 | CID000119582 | |
| Drug | Ethylnitrosourea | 4.35e-05 | 291 | 100 | 8 | ctd:D005038 | |
| Drug | 1-(1-methanesulfonylpiperidin-4-yl)-3-(4-trifluoromethoxyphenyl)urea | 4.42e-05 | 16 | 100 | 3 | ctd:C561619 | |
| Drug | AdOx | 4.42e-05 | 16 | 100 | 3 | CID000099920 | |
| Drug | aurothioglucose | 4.83e-05 | 90 | 100 | 5 | CID000006104 | |
| Drug | AC1MZZID | 5.71e-05 | 3 | 100 | 2 | CID003908947 | |
| Drug | propylphosphonic acid | 5.71e-05 | 3 | 100 | 2 | CID006328099 | |
| Drug | Mecasermin | 5.71e-05 | 3 | 100 | 2 | DB01277 | |
| Drug | BM-223 | 5.71e-05 | 3 | 100 | 2 | CID002760592 | |
| Drug | AC1L1H8N | 5.71e-05 | 3 | 100 | 2 | CID000004023 | |
| Drug | BM 208 | 5.71e-05 | 3 | 100 | 2 | CID002782755 | |
| Drug | 2,4-dihydroxyphenylacetic acid | 5.71e-05 | 3 | 100 | 2 | CID000069199 | |
| Drug | avermectin | 5.88e-05 | 48 | 100 | 4 | CID006450460 | |
| Drug | vanadyl | 6.34e-05 | 307 | 100 | 8 | CID000061671 | |
| Drug | Cgp-42700 | 6.39e-05 | 18 | 100 | 3 | CID000188390 | |
| Drug | Nile red | 6.91e-05 | 50 | 100 | 4 | CID000065182 | |
| Drug | ethyl methylphosphinate | 7.47e-05 | 51 | 100 | 4 | CID006328184 | |
| Drug | LY354740 | 7.47e-05 | 51 | 100 | 4 | CID000114827 | |
| Drug | II-E | 8.38e-05 | 101 | 100 | 5 | CID006540268 | |
| Drug | bifenthrin | 9.20e-05 | 103 | 100 | 5 | ctd:C099952 | |
| Drug | loperamide | 1.01e-04 | 105 | 100 | 5 | CID000003954 | |
| Drug | Azitidin | 1.03e-04 | 169 | 100 | 6 | CID000005726 | |
| Drug | riddelliine | 1.08e-04 | 56 | 100 | 4 | ctd:C013672 | |
| Drug | racemethorphan | 1.10e-04 | 107 | 100 | 5 | CID000003008 | |
| Drug | NSC638615 | 1.10e-04 | 107 | 100 | 5 | CID000097535 | |
| Drug | Nicorette | ROCK2 UGT1A6 CYP21A2 GRID2 GRIK1 GRIN2B BMP7 PRKCE PRKCI EIF2AK3 | 1.12e-04 | 529 | 100 | 10 | CID000000942 |
| Drug | AC1L1GKK | 1.14e-04 | 4 | 100 | 2 | CID000003725 | |
| Drug | Xanthenes | 1.14e-04 | 4 | 100 | 2 | ctd:D014966 | |
| Drug | SN-38 carboxylate form | 1.14e-04 | 4 | 100 | 2 | CID000443148 | |
| Drug | hypericin | 1.15e-04 | 108 | 100 | 5 | CID005281051 | |
| Drug | imatinib | 1.17e-04 | 430 | 100 | 9 | CID000005291 | |
| Drug | U0126 | 1.17e-04 | 430 | 100 | 9 | CID000005637 | |
| Drug | englitazone | 1.19e-04 | 22 | 100 | 3 | CID000060303 | |
| Drug | DAPH2 | 1.24e-04 | 58 | 100 | 4 | CID006711154 | |
| Drug | lithocholyltaurine | 1.24e-04 | 175 | 100 | 6 | CID000010595 | |
| Drug | dichloromethanediamine | PCSK5 CABP1 TNFRSF25 BIRC3 ABCB1 IGF1R EPHA2 PAM PRKCE PRKCI | 1.31e-04 | 539 | 100 | 10 | CID005311048 |
| Drug | 3-nitropropionic acid | 1.36e-04 | 178 | 100 | 6 | CID000001678 | |
| Drug | YM90K | 1.37e-04 | 23 | 100 | 3 | CID005486547 | |
| Drug | 3,5-dihydroxyphenylglycine | 1.41e-04 | 60 | 100 | 4 | CID000108001 | |
| Drug | CGP 39653 | 1.56e-04 | 24 | 100 | 3 | CID006437837 | |
| Drug | Letrozole [112809-51-5]; Up 200; 14uM; HL60; HT_HG-U133A | 1.68e-04 | 185 | 100 | 6 | 2916_UP | |
| Drug | adenosine 3',5'-cyclic phosphate | CARM1 CYP21A2 INSR BIRC3 GRIK1 AKAP8L ATF6 LATS1 FBP1 PAM PRKCE PRKCI TAT | 1.68e-04 | 907 | 100 | 13 | CID000000274 |
| Drug | AC1ND2OB | 1.70e-04 | 265 | 100 | 7 | CID004568637 | |
| Drug | AC1L1D59 | 1.74e-04 | 266 | 100 | 7 | CID000002199 | |
| Drug | gavestinel | 1.76e-04 | 25 | 100 | 3 | CID006450546 | |
| Drug | Dexamethasone acetate [1177-87-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 1.83e-04 | 188 | 100 | 6 | 2079_DN | |
| Drug | PQ401 | 1.89e-04 | 5 | 100 | 2 | CID009549305 | |
| Drug | phloxine | 1.89e-04 | 5 | 100 | 2 | ctd:C085059 | |
| Drug | SP600125 | 1.97e-04 | 362 | 100 | 8 | CID000008515 | |
| Drug | BMS-764459 | 1.99e-04 | 26 | 100 | 3 | ctd:C584056 | |
| Drug | 3-octanone | 1.99e-04 | 26 | 100 | 3 | CID000246728 | |
| Drug | PHA-00846566E [724718-26-7]; Down 200; 10uM; PC3; HT_HG-U133A | 2.00e-04 | 191 | 100 | 6 | 7086_DN | |
| Drug | fluo-3 | 2.04e-04 | 122 | 100 | 5 | CID000104978 | |
| Drug | tyrphostin 25 | 2.04e-04 | 122 | 100 | 5 | CID000002061 | |
| Drug | ethoxytriethyleneglycol | 2.05e-04 | 66 | 100 | 4 | CID000008190 | |
| Drug | Diclofenac | ROCK2 UGT1A6 INSR STAT6 ABCB1 GSTA3 CDC7 IGF1R PRKCI EIF2AK3 | 2.05e-04 | 570 | 100 | 10 | ctd:D004008 |
| Drug | 17-hydroxyprogesterone | 2.12e-04 | 123 | 100 | 5 | CID000006238 | |
| Drug | palmitate | 2.16e-04 | 367 | 100 | 8 | CID000000985 | |
| Drug | Dibucaine [85-79-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.17e-04 | 194 | 100 | 6 | 4149_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.17e-04 | 194 | 100 | 6 | 1219_DN | |
| Drug | Ampyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A | 2.17e-04 | 194 | 100 | 6 | 2086_DN | |
| Drug | NSC618487 | ROCK2 TNFRSF25 CYP21A2 INSR BIRC3 GRIK1 GRIN2B YES1 ABCB1 EPHA2 PRKCE PRKCI FGR | 2.22e-04 | 933 | 100 | 13 | CID000005279 |
| Drug | ilmofosine | 2.23e-04 | 27 | 100 | 3 | CID000055008 | |
| Drug | pseudohypericin | 2.23e-04 | 27 | 100 | 3 | CID005281751 | |
| Drug | L-689,560 | 2.23e-04 | 27 | 100 | 3 | CID000121918 | |
| Drug | Parbendazole [14255-87-9]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 4357_UP | |
| Drug | Mafenide hydrochloride [138-37-4]; Down 200; 18uM; PC3; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 5079_DN | |
| Drug | Penbutolol sulfate [38363-32-5]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 3534_DN | |
| Drug | Dimethadione [695-53-4]; Up 200; 31uM; HL60; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 3029_UP | |
| Drug | ponatinib | 2.30e-04 | 68 | 100 | 4 | ctd:C545373 | |
| Drug | Testosterone Propionate | 2.30e-04 | 68 | 100 | 4 | ctd:D043343 | |
| Drug | 0198306-0000 [212631-61-3]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.36e-04 | 197 | 100 | 6 | 7064_DN | |
| Drug | Flavoxate hydrochloride [3717-88-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 2.36e-04 | 197 | 100 | 6 | 7405_UP | |
| Drug | Ornidazole [16773-42-5]; Down 200; 18.2uM; PC3; HT_HG-U133A | 2.43e-04 | 198 | 100 | 6 | 5064_DN | |
| Disease | high grade glioma (implicated_via_orthology) | 8.28e-09 | 44 | 100 | 6 | DOID:3070 (implicated_via_orthology) | |
| Disease | diabetes mellitus (implicated_via_orthology) | 1.75e-06 | 26 | 100 | 4 | DOID:9351 (implicated_via_orthology) | |
| Disease | alcohol dependence (implicated_via_orthology) | 3.13e-06 | 9 | 100 | 3 | DOID:0050741 (implicated_via_orthology) | |
| Disease | sleep disorder (implicated_via_orthology) | 6.11e-06 | 11 | 100 | 3 | DOID:535 (implicated_via_orthology) | |
| Disease | diabetic neuropathy (implicated_via_orthology) | 1.34e-05 | 14 | 100 | 3 | DOID:9743 (implicated_via_orthology) | |
| Disease | Metastatic melanoma | 3.45e-05 | 54 | 100 | 4 | C0278883 | |
| Disease | cancer (implicated_via_orthology) | 3.68e-05 | 268 | 100 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | sphingomyelin 24:1 measurement | 6.37e-05 | 23 | 100 | 3 | EFO_0010398 | |
| Disease | carcinoma (implicated_via_orthology) | 6.75e-05 | 64 | 100 | 4 | DOID:305 (implicated_via_orthology) | |
| Disease | fetal alcohol spectrum disorder (biomarker_via_orthology) | 6.79e-05 | 4 | 100 | 2 | DOID:0050696 (biomarker_via_orthology) | |
| Disease | Neonatal diabetes mellitus | 8.23e-05 | 25 | 100 | 3 | C0158981 | |
| Disease | body weight | PCSK5 NEXMIF CYP21A2 INSR MDGA2 GRID2 DNAH14 IGF1R ABCC8 HACE1 PRKCE FGR EIF2AK3 NIPBL | 9.00e-05 | 1261 | 100 | 14 | EFO_0004338 |
| Disease | gestational diabetes (biomarker_via_orthology) | 1.13e-04 | 5 | 100 | 2 | DOID:11714 (biomarker_via_orthology) | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 1.16e-04 | 28 | 100 | 3 | DOID:4194 (implicated_via_orthology) | |
| Disease | colorectal cancer (implicated_via_orthology) | 1.43e-04 | 30 | 100 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | GlcNAc sulfate conjugate of C21H34O2 steroid measurement | 1.69e-04 | 6 | 100 | 2 | EFO_0800663 | |
| Disease | toxic encephalopathy (is_implicated_in) | 1.69e-04 | 6 | 100 | 2 | DOID:3602 (is_implicated_in) | |
| Disease | Epilepsy, Cryptogenic | 1.77e-04 | 82 | 100 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 1.77e-04 | 82 | 100 | 4 | C0751111 | |
| Disease | Aura | 1.77e-04 | 82 | 100 | 4 | C0236018 | |
| Disease | Parkinson Disease | 2.04e-04 | 85 | 100 | 4 | C0030567 | |
| Disease | gestational diabetes (is_implicated_in) | 3.14e-04 | 8 | 100 | 2 | DOID:11714 (is_implicated_in) | |
| Disease | Ventricular Septal Defects | 3.14e-04 | 8 | 100 | 2 | C0018818 | |
| Disease | pneumococcal meningitis | 3.14e-04 | 8 | 100 | 2 | EFO_1001114 | |
| Disease | Familial hyperinsulinism | 3.14e-04 | 8 | 100 | 2 | cv:C3888018 | |
| Disease | multiple system atrophy | 3.41e-04 | 40 | 100 | 3 | EFO_1001050 | |
| Disease | cortical thickness | PRTG PLXND1 MINDY2 BMP7 CELSR1 IGF1R PMPCA MRO PAM MICAL3 ULK2 WNK2 | 3.87e-04 | 1113 | 100 | 12 | EFO_0004840 |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 4.57e-04 | 105 | 100 | 4 | DOID:9352 (implicated_via_orthology) | |
| Disease | Gastric Adenocarcinoma | 4.83e-04 | 45 | 100 | 3 | C0278701 | |
| Disease | Epilepsy | 5.26e-04 | 109 | 100 | 4 | C0014544 | |
| Disease | kidney cancer (implicated_via_orthology) | 6.13e-04 | 11 | 100 | 2 | DOID:263 (implicated_via_orthology) | |
| Disease | insomnia, bilirubin measurement | 6.13e-04 | 11 | 100 | 2 | EFO_0004570, EFO_0004698 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 6.21e-04 | 49 | 100 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | glucose metabolism measurement, age-related hearing impairment | 7.40e-04 | 52 | 100 | 3 | EFO_0005782, EFO_0009367 | |
| Disease | Peripheral Nervous System Diseases | 8.26e-04 | 54 | 100 | 3 | C4721453 | |
| Disease | renal cell carcinoma (is_marker_for) | 9.60e-04 | 128 | 100 | 4 | DOID:4450 (is_marker_for) | |
| Disease | serum gamma-glutamyl transferase measurement | CABP1 UGT1A6 CYP21A2 YES1 IGF1R EPHA2 HACE1 MICAL3 ULK1 SIPA1L2 | 1.08e-03 | 914 | 100 | 10 | EFO_0004532 |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 1.16e-03 | 15 | 100 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | Liver Cirrhosis, Experimental | 1.28e-03 | 774 | 100 | 9 | C0023893 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.30e-03 | 139 | 100 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | Monogenic diabetes | 1.32e-03 | 16 | 100 | 2 | C3888631 | |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 1.42e-03 | 65 | 100 | 3 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 1.50e-03 | 17 | 100 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 1.60e-03 | 147 | 100 | 4 | DOID:9352 (biomarker_via_orthology) | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 1.61e-03 | 801 | 100 | 9 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | Adrenocortical carcinoma | 1.68e-03 | 18 | 100 | 2 | C0206686 | |
| Disease | Congenital hernia of foramen of Morgagni | 1.87e-03 | 19 | 100 | 2 | C0265699 | |
| Disease | Congenital hernia of foramen of Bochdalek | 1.87e-03 | 19 | 100 | 2 | C0265700 | |
| Disease | prostate cancer (is_marker_for) | 1.99e-03 | 156 | 100 | 4 | DOID:10283 (is_marker_for) | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 2.08e-03 | 20 | 100 | 2 | DOID:2526 (is_implicated_in) | |
| Disease | epilepsy (biomarker_via_orthology) | 2.29e-03 | 21 | 100 | 2 | DOID:1826 (biomarker_via_orthology) | |
| Disease | Congenital diaphragmatic hernia | 2.29e-03 | 21 | 100 | 2 | C0235833 | |
| Disease | Lung diseases | 2.39e-03 | 78 | 100 | 3 | C0024115 | |
| Disease | Lewy Body Disease | 2.51e-03 | 22 | 100 | 2 | C0752347 | |
| Disease | cotinine measurement | 2.75e-03 | 23 | 100 | 2 | EFO_0007813 | |
| Disease | Allodynia | 2.95e-03 | 84 | 100 | 3 | C0458247 | |
| Disease | Mechanical Allodynia | 2.95e-03 | 84 | 100 | 3 | C2936719 | |
| Disease | Hyperalgesia, Secondary | 2.95e-03 | 84 | 100 | 3 | C0751212 | |
| Disease | Hyperalgesia, Primary | 2.95e-03 | 84 | 100 | 3 | C0751211 | |
| Disease | Hyperalgesia, Thermal | 2.95e-03 | 84 | 100 | 3 | C0751214 | |
| Disease | Tactile Allodynia | 2.95e-03 | 84 | 100 | 3 | C0751213 | |
| Disease | Hyperalgesia | 2.95e-03 | 84 | 100 | 3 | C0020429 | |
| Disease | fasting blood glucose measurement | 2.98e-03 | 287 | 100 | 5 | EFO_0004465 | |
| Disease | FEV change measurement, response to zileuton | 3.24e-03 | 25 | 100 | 2 | EFO_0005921, EFO_0007676 | |
| Disease | colorectal cancer, hormone replacement therapy | 3.36e-03 | 88 | 100 | 3 | EFO_0003961, MONDO_0005575 | |
| Disease | descending aortic diameter | 3.36e-03 | 88 | 100 | 3 | EFO_0021788 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GMQNSLMMLVDTPDY | 156 | P83436 | |
| YVMVQDMLSPSPMER | 1051 | Q9NZJ5 | |
| MVTMALVDANYEMPG | 221 | Q8TDN7 | |
| GLLDGMMTTEAALMY | 311 | P39086 | |
| MESMTYLTAGMLDQP | 356 | Q9H845 | |
| MMNTPVINAAVEMGF | 376 | Q13489 | |
| IAGMYLMMSVDTVIP | 196 | P19021 | |
| NYGPMSMLEQDSRRM | 391 | P18850 | |
| RIDPDSGTMYTMMEL | 836 | Q9NYQ6 | |
| MEPVNMESMGHPEIY | 26 | Q8IWG1 | |
| MFMLDLYNAMAVEEG | 81 | P18075 | |
| TMGYMPTEMELIELS | 256 | Q9NZU7 | |
| FVAGAMMMPSTVLAY | 1091 | Q96F81 | |
| KQDPNYLATMAMDGM | 231 | P61962 | |
| YLATMAMDGMEVVIL | 236 | P61962 | |
| MVPHLETDMMQGGVY | 101 | Q9ULX6 | |
| GSPMMKAAMYSVEIT | 161 | O75781 | |
| PLMMLVFGEMTDIFA | 66 | P08183 | |
| MELSCSEAPLYGQMM | 1 | Q8N1W1 | |
| PGGAISNMYAMMIAR | 241 | Q05329 | |
| VLMFEMMAGRSPFDI | 441 | P41743 | |
| MASVGEPDKLSMVMY | 601 | Q7RTP6 | |
| AMYLMVGIEMEHFPE | 371 | P17735 | |
| SMPVMILTEFMENGA | 686 | P54760 | |
| DMAAQVAEGMAYMER | 361 | P09769 | |
| VMDYIPGGDMMSLLI | 781 | O95835 | |
| PEDGMAVCMFMQNTL | 126 | Q9NTX5 | |
| LMYEMMAGQPPFEAD | 596 | Q02156 | |
| GLKEMASSNPVYMEM | 811 | Q9UPZ3 | |
| MAPEMDQFYRSTMAI | 1 | Q6UXY1 | |
| SEPMGYMLFNERMLE | 256 | Q86X55 | |
| MMDYMLQGVAQPSME | 256 | P08686 | |
| MAAFSEMGVMPEIAQ | 1 | Q92499 | |
| LIDMYTEGMADLNEM | 91 | Q16772 | |
| KMIQMAGEIADGMAY | 1111 | P08069 | |
| GEVPYTTLATRMMMG | 621 | O43424 | |
| LYGFGLMDAEAMVME | 441 | Q92824 | |
| PMTVMVYNCAMGSPD | 841 | Q9Y4D7 | |
| QFQEMMADSMFVIPA | 406 | O00748 | |
| VTMDPSCEVGMAYSM | 221 | Q969I3 | |
| DNETAVYTLMPMVMA | 26 | Q8IYU2 | |
| NSSDMDGEPMYIQMV | 1476 | Q6KC79 | |
| LMQEHMYEPAGLMFA | 996 | O95163 | |
| HMAMRNLGTMAYEAP | 66 | Q9BYG7 | |
| PDAETDQIMMISYMI | 286 | Q07864 | |
| MIQMAAEIADGMAYL | 1136 | P06213 | |
| MPDGSMQMESYDGTL | 486 | Q7Z553 | |
| YMPMGASQMSDHVTQ | 496 | Q2VWP7 | |
| ECNPMAYVMEKAGGM | 281 | P09467 | |
| MCRGIPTYMAEEMQE | 141 | Q9NS71 | |
| MYMMIESKSPIQVGG | 271 | A2RU49 | |
| DCMRTLGYMPTEMEL | 156 | P57796 | |
| MEASLGIQMDEPMAF | 1 | O00311 | |
| KPMMIITEYMENGAL | 686 | P29317 | |
| MSELDPAVMDQFYMK | 181 | P17707 | |
| ALFRTVAMMVPDYAM | 1446 | Q8WXX0 | |
| PMEVFSIDSMSGRMY | 216 | P55283 | |
| LIFIDDMNMPVSDMY | 1926 | Q0VDD8 | |
| MMQTIGQKYCMDPAV | 71 | Q8N1E2 | |
| YRAEMDNPEMFDLMP | 521 | P10911 | |
| EMIQMAGEIADGMAY | 1091 | P14616 | |
| MMQEAMSAFPGIDEA | 131 | O43681 | |
| MKEAMEIMPETLEYG | 116 | Q8IVF4 | |
| MDDMNMPRVDEYGTQ | 2521 | Q8IVF4 | |
| AQPQMMVVSDVADMF | 566 | P53992 | |
| AMGSTECVLLPMMAY | 106 | Q8NGS4 | |
| MREIPEMEGYMKAEV | 131 | A6NES4 | |
| MMEIITAEQLMEYLG | 286 | Q8NBR6 | |
| EEDFIPFAVLNMMMG | 331 | Q10713 | |
| EYSEENGPLMMQVGM | 701 | Q8IZX4 | |
| GMADVQRFMMASIEP | 1326 | Q5QGS0 | |
| ECPGMYSEMDVMSTA | 1416 | Q9P2F8 | |
| AMGYQPLVTMDDAME | 346 | Q15738 | |
| FIPGSALNGMVEMMD | 501 | Q9NSE4 | |
| MAITGIVMMAYADNF | 311 | A4IF30 | |
| NTMDDQGMTPLMYAC | 516 | Q8N961 | |
| LYMPAGMAFMAAVTS | 106 | Q09428 | |
| VMNMYGDLVMDTVPE | 406 | Q9H4L4 | |
| RAVSEMALAMGFMPV | 176 | Q658P3 | |
| VVLRGPSAEMQGYMM | 746 | Q96PV0 | |
| PSAEMQGYMMRDLNS | 751 | Q96PV0 | |
| LQMPTMVPSYDLGMA | 661 | P42226 | |
| VYVMGGVAMSEMRAA | 536 | Q15833 | |
| MSLMLDDQPPMEAQY | 1 | Q9H3S3 | |
| PMISGQDEDMLRYMI | 266 | Q9UJ04 | |
| YMVMEYMPGGDLVNL | 166 | O75116 | |
| DNGMAIFPMIYMPAA | 3506 | Q86WI1 | |
| AMMLQPGPQLYDVMD | 326 | Q93038 | |
| VAVGTAAEMMLMPYG | 291 | Q9UBD6 | |
| GSPMYMAPEVIMSQH | 176 | Q8IYT8 | |
| ISMYARAGIDDMSME | 141 | Q9ULT0 | |
| DYPEGIEMASMEMAN | 291 | Q6UXY8 | |
| AFGMCMLEMATSEYP | 381 | Q9Y3S1 | |
| GVYESICNGVPMVMM | 376 | P19224 | |
| YATILEMQAMMTFDP | 61 | Q5SRH9 | |
| MTFDPQDILLAGNMM | 71 | Q5SRH9 | |
| DGENMYMSMTEPSQD | 36 | O94900 | |
| TMYTDIMDPMLNAVQ | 256 | Q9H347 | |
| MCPPVSMRYEEEGMS | 1 | Q8NA77 | |
| MYMAPEVIMSQHYDG | 186 | O75385 | |
| AVPMIEGYMFEEHEM | 776 | Q9H3U1 | |
| GMLITGSSVMDMYPL | 426 | B1ANS9 | |
| MAAQIADGMAYIERM | 376 | P07947 | |
| DNMAGVFYMLGAAMA | 816 | Q13224 |